D. Judge

发表

Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?

H. Firth, S. Hutchinson, A. Furger, 2003, Human molecular genetics.

Current treatment of adult Duchenne muscular dystrophy.

D. Judge, K. Wagner, N. Lechtzin, 2007, Biochimica et biophysica acta.

Mitral valve disease—morphology and mechanisms

Francesca N. Delling, E. Schwammenthal, R. Levine, 2015, Nature Reviews Cardiology.

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

R. Falk, D. Judge, M. Maurer, 2020, Cardiovascular Drugs and Therapy.

Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).

R. Falk, M. Skinner, D. Judge, 2012, American heart journal.

Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis.

S. Russell, D. Judge, G. Stevens, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Case Report Case Report of a Patient with Left Ventricular Assistance Device Undergoing Chemotherapy for a New Diagnosis of Lung Cancer

L. Chu, D. Judge, A. Zeidan, 2015 .

Case Report of a Patient with Left Ventricular Assistance Device Undergoing Chemotherapy for a New Diagnosis of Lung Cancer

L. Chu, D. Judge, A. Zeidan, 2015, Case reports in oncological medicine.

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

Marc K. Halushka, Daniel B. Rifkin, M. Halushka, 2006, Science.

Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice

Samarjit Patnaik, J. Marugan, D. Judge, 2011, Science.

Etiology of limb girdle muscular dystrophy 1D/1E determined by laser capture microdissection proteomics

H. Steen, S. Greenberg, D. Judge, 2012, Annals of neurology.

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

Michael J Ackerman, Stephan Willems, Silvia G Priori, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance

Theodore P Abraham, Marc K Halushka, David A Bluemke, 2012, Journal of Cardiovascular Magnetic Resonance.

The Mitral Valve in Hypertrophic Cardiomyopathy

R. Levine, D. Judge, A. Hagège, 2011, Journal of cardiovascular translational research.

Advances in Induced Pluripotent Stem Cells, Genomics, Biomarkers, and Antiplatelet Therapy Highlights of the Year in JCTR 2013

A. Terzic, D. Judge, P. Iaizzo, 2014, Journal of Cardiovascular Translational Research.

KLOTHO allele status and the risk of early-onset occult coronary artery disease.

D. Arking, L. Becker, D. Becker, 2003, American journal of human genetics.

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy

R. Hauer, H. Calkins, A. Wilde, 2018, PloS one.

Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

S. Russell, H. Calkins, D. Bluemke, 2009, Circulation. Cardiovascular genetics.

Risk Stratification in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers

S. Russell, H. Calkins, T. Abraham, 2012, Circulation. Arrhythmia and electrophysiology.

Heart Failure as a Consequence of Genetic Cardiomyopathy

D. Judge, 2020 .

Contemporary Cardiac Issues in Duchenne Muscular Dystrophy

E. Hoffman, D. Judge, G. Pearson, 2015, Circulation.

Loss of Elastic Fiber Integrity and Reduction of Vascular Smooth Muscle Contraction Resulting From the Upregulated Activities of Matrix Metalloproteinase-2 and -9 in the Thoracic Aortic Aneurysm in Marfan Syndrome

D. Judge, H. Dietz, C. van Breemen, 2007, Circulation research.

Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome

D. Judge, H. Dietz, A. Chung, 2007, British journal of pharmacology.

Genetic aetiologies should be considered in paediatric cases of acute heart failure presumed to be myocarditis

M. Halushka, D. Judge, W. Ravekes, 2019, Cardiology in the Young.

DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Hugh Calkins, David A Bluemke, Crystal Tichnell, 2006, American journal of human genetics.

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report

P. Lambiase, H. Calkins, D. Corrado, 2019, European journal of heart failure.

Managing Secondary Genomic Findings Associated With Arrhythmogenic Right Ventricular Cardiomyopathy: Case Studies and Proposal for Clinical Surveillance

Brandon K. Fornwalt, H. Calkins, D. Judge, 2018, Circulation. Genomic and precision medicine.

Arrhythmogenic Cardiomyopathy.

D. Corrado, D. Judge, C. Basso, 2017, Circulation research.

Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy.

A. Kleber, D. Judge, J. Saffitz, 2016, JCI insight.

Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.

R. Hauer, S. Russell, D. Atsma, 2015, European heart journal.

Exercise has a Disproportionate Role in the Pathogenesis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in Patients Without Desmosomal Mutations

S. Russell, H. Calkins, D. Judge, 2014, Journal of the American Heart Association.

Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

S. Russell, H. Calkins, D. Judge, 2013, Journal of the American College of Cardiology.

Shared Desmosome Gene Findings in Early and Late Onset Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

H. Calkins, D. Judge, D. Dalal, 2010, Journal of cardiovascular translational research.

Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia

S. Russell, H. Calkins, T. Abraham, 2009, Circulation.

Mechanisms of Disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy

H. Calkins, D. Judge, M. Awad, 2008, Nature Clinical Practice Cardiovascular Medicine.

Genetic Evaluation of Familial Cardiomyopathy

Nicole M. Johnson, D. Judge, 2008, Journal of cardiovascular translational research.

Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

S. Russell, H. Calkins, D. Bluemke, 2007, Journal of the American College of Cardiology.

Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

S. Russell, H. Calkins, D. Bluemke, 2006, Journal of the American College of Cardiology.

Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2

S. Russell, H. Calkins, D. Bluemke, 2006, Circulation.

Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities

R. Levine, R. Markwald, D. Judge, 2015, Journal of cardiovascular development and disease.

Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years

D. Judge, L. Amass, M. Stewart, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy

Y. Liu, D. Judge, G. Ebenezer, 2017, Annals of neurology.

The Role of Genetics in Peripartum Cardiomyopathy

D. Judge, Y. Lee, 2017, Journal of Cardiovascular Translational Research.

Genetic Dilated Cardiomyopathy Due to TTN Variants without Known Familial Disease.

D. Judge, L. Barouch, C. James, 2020, Circulation Genomic and Precision Medicine.

Bringing Autopsies Into the Molecular Genetic Era

D. Judge, E. Brown, 2018, Circulation.

Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers.

H. Calkins, D. Judge, H. Tandri, 2016, Heart rhythm.

Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis

M. Link, R. Hauer, L. Mestroni, 2019, European heart journal.

OP-EHEA190679 1..16

M. Link, R. Hauer, L. Mestroni, 2019 .

Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.

D. Judge, J. Saffitz, L. Tung, 2019, Circulation.

Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells

H. Calkins, A. Kleber, D. Judge, 2016, Circulation. Arrhythmia and electrophysiology.

Further evidence of harm from exercise in ARVD/C.

D. Judge, S. Chelko, 2015, Journal of the American College of Cardiology.

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Cardiac Sarcoidosis: Distinguishing Features When the Diagnosis Is Unclear

H. Calkins, D. Judge, S. Nazarian, 2014, Circulation. Arrhythmia and electrophysiology.

Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy

R. Hauer, H. Calkins, D. J. Veldhuisen, 2012, European journal of heart failure.

Phenotypic diversity arising from a single mutation.

D. Judge, 2009, Heart Rhythm.

Losartan in Marfan Syndrome—Beyond Blood Pressure Lowering Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome. Science 312: 117–121, 2006

M. Halushka, D. Judge, H. Dietz, 2006 .

Yield of serial evaluation in at-risk family members of patients with ARVD/C.

Stefan L. Zimmerman, H. Calkins, D. Bluemke, 2014, Journal of the American College of Cardiology.

Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

Stefan L. Zimmerman, H. Calkins, D. Bluemke, 2013, Journal of the American College of Cardiology.

Mitral Valve Disease in Marfan Syndrome and Related Disorders

D. Judge, H. Dietz, J. Habashi, 2011, Journal of cardiovascular translational research.

TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study.

G. Ewald, M. Wheeler, L. Hindorff, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy.

G. Ewald, M. Wheeler, S. Gottlieb, 2022, JAMA.

Positive family history decreases diagnosis time by over 200%

D. Judge, E. Brown, Johana Fajardo, 2019, Amyloid: Journal of Protein Folding Disorders.

Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

S. Russell, H. Calkins, M. Halushka, 2012, Journal of the American College of Cardiology.

The response to cardiac resynchronization therapy in LMNA cardiomyopathy

L. Mestroni, M. Wheeler, D. Judge, 2022, European journal of heart failure.

Genotype and Phenotype of Transthyretin Cardiac Amyloidosis

Sanjiv J. Shah, S. Gottlieb, D. Judge, 2022 .

A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.

M. Halushka, D. Judge, H. Dietz, 2014, Journal of the American Society of Nephrology : JASN.

Novel and Highly Lethal NKX2.5 Missense Mutation in a Family With Sudden Death and Ventricular Arrhythmia

Nicole M. Johnson, D. Judge, J. Crosson, 2014, Pediatric Cardiology.

Use of a Coronary Sinus Lead and Biventricular ICD to Correct a Sensing Abnormality in a Patient with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

H. Calkins, D. Judge, K. Bilchick, 2006, Journal of cardiovascular electrophysiology.

Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

R. Hauer, S. Russell, H. Calkins, 2017, JAMA cardiology.

Mutations in Alström Protein Impair Terminal Differentiation of Cardiomyocytes

L. Fernandez, Chulan Kwon, D. Valle, 2014, Nature Communications.

Cardiovascular Disease in Osteogenesis Imperfecta

D. Judge, 2014 .

Therapy for Marfan Syndrome

D. Judge, H. Dietz, 2006, Science.

Hypermobile Ehlers‐Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes

D. Judge, R. Norris, M. Lavallee, 2020, Developmental dynamics : an official publication of the American Association of Anatomists.

Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice.

Dong I. Lee, D. Kass, D. Judge, 2017, JCI insight.

Why should cardiologists consider genetic testing for hypertrophic cardiomyopathy?

D. Judge, 2015, JACC. Heart failure.

Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome

D. Judge, P. Handford, D. Macaya, 2010, Science Translational Medicine.

Toward an Understanding of Dural Ectasia: A Light Microscopy Study in a Murine Model of Marfan Syndrome

Kevin B. Jones, D. Judge, H. Dietz, 2005, Spine.

Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine

D. Judge, B. Ibáñez, E. Lara-Pezzi, 2015, Journal of Cardiovascular Translational Research.

Response to Letters Regarding Article, “Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia”

S. Russell, H. Calkins, T. Abraham, 2010 .

Comparison of Features of Fatal Versus Nonfatal Cardiac Arrest in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

H. Calkins, D. Judge, S. Rizzo, 2017, The American journal of cardiology.

Relationship between monoclonal gammopathy and cardiac amyloid type.

M. Halushka, D. Judge, A. Dispenzieri, 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Protein molecular modeling techniques investigating novel TAB2 variant R347X causing cardiomyopathy and congenital heart defects in multigenerational family

D. Judge, T. Caulfield, P. Atwal, 2018, Molecular genetics & genomic medicine.

Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR‐ACT

D. Judge, J. Nativi-Nicolau, M. Grogan, 2021, ESC heart failure.

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2022, European heart journal.

Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2020, Circulation. Arrhythmia and electrophysiology.

Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis

D. Judge, A. Kristen, K. Berthet, 2015, Journal of Cardiovascular Translational Research.

SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients.

S. Russell, D. Judge, T. Markman, 2020, Heart, Lung and Circulation.

The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus.

D. Judge, J. Mogensen, T. Šarić, 2015, European heart journal.

Seven factors predict a delayed diagnosis of cardiac amyloidosis

M. Halushka, D. Judge, L. Barouch, 2018, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Cardiovascular genetics provides new insights for early onset arrhythmogenic right ventricular dysplasia/cardiomyopathy.

D. Judge, 2011, Heart Rhythm.

Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2

H. Calkins, T. Abraham, D. Judge, 2006, Human mutation.

Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis

R. Hauer, L. Mestroni, H. Calkins, 2017, Cardiovascular research.

Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

S. Russell, H. Calkins, T. Abraham, 2012, Circulation. Arrhythmia and electrophysiology.

Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

H. Calkins, D. Judge, S. Nazarian, 2015, Heart rhythm.

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset Disease.

R. Hauer, H. Calkins, D. Judge, 2015, JACC. Clinical electrophysiology.

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications

H. Calkins, I. Kamel, D. Judge, 2017, Journal of the American Heart Association.

Inheritance Impacts Mitral Valve Insufficiency.

D. Judge, R. Norris, 2017, Circulation: Cardiovascular Genetics.

Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy.

S. Russell, M. Halushka, D. Judge, 2017, Journal of cardiac failure.

Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.

R. Hauer, H. Calkins, D. Judge, 2017, Heart rhythm.

Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity.

R. Hauer, H. Calkins, D. Judge, 2013, Heart Rhythm.

Heart failure and genomics.

Nicole M. Johnson, D. Judge, A. Cirino, 2007, Journal of the American College of Cardiology.

Abstract 14092: Clinical Course and Age Dependent Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated Desmosomal Mutation Carriers

H. Calkins, T. Abraham, D. Judge, 2011 .

Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy.

H. Calkins, D. Judge, A. Krahn, 2013, Journal of the American College of Cardiology.

REPORT DSG2 Mutations Contribute to Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

S. Russell, H. Calkins, D. Bluemke, 2006 .

Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations.

Stefan L. Zimmerman, H. Calkins, D. Bluemke, 2015, JACC. Cardiovascular imaging.

Lack of Relationship Between Serum Cardiac Troponin I Level and Giant Cell Myocarditis Diagnosis and Outcomes.

S. Russell, M. Halushka, D. Judge, 2016, Journal of cardiac failure.

International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework

D. Judge, R. L. Lekanne Deprez, R. Hershberger, 2021, Circulation. Genomic and precision medicine.

Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study.

Amy Daly, Hugh Calkins, David A Bluemke, 2009, Journal of the American College of Cardiology.

Influence of Panel Selection on Yield of Clinically Useful Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Families.

H. Calkins, D. Judge, J. P. van Tintelen, 2020, Circulation. Genomic and precision medicine.

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2019 .

Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

H. Calkins, I. Kamel, D. Judge, 2018, Circulation: Arrhythmia and Electrophysiology.

Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy.

H. Calkins, D. Judge, P. Ganz, 2012, Heart rhythm.

A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations

D. Judge, P. Ramos, K. Hunt, 2022, Implementation Science Communications.

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

E. Nordh, Yi-Chung Lee, R. Sommerville, 2020, Lancet Neurology.

Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

S. Russell, H. Calkins, D. Judge, 2018, Journal of Cardiac Failure.

Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis

M. Halushka, D. Judge, J. Stone, 2015, Journal of Cardiovascular Translational Research.

Familial amyloid cardiomyopathy due to TTR mutations: an underdiagnosed cause of restrictive cardiomyopathy [corrected].

D. Judge, F. Ruberg, M. Maurer, 2009, Journal of Cardiac Failure.

Erratum: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies (Europace (2011) 13 (1077-1109) DOI: 10.1093/europace/eur245)

H. Calkins, P. Ellinor, S. Priori, 2012 .

Reversible cardiomyopathy caused by administration of interferon α

M. Halushka, D. Judge, E. Kasper, 2005, Nature Clinical Practice Cardiovascular Medicine.

Reversible dilated cardiomyopathy associated with glucagonoma

D. Judge, J. Chew, K. Chang-Chretien, 2004, Heart.

Erratum: "Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy" (Science Translational Medicine (2014) 6:261 (261er6))

H. Calkins, A. Kleber, D. Judge, 2014 .

Implantable Cardioverter-De fi brillator Therapy in Arrhythmogenic Right Ventricular Dysplasia / Cardiomyopathy : Predictors of Appropriate Therapy , Outcomes , and Complications

H. Calkins, I. Kamel, D. Judge, 2017 .

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Sanjiv J. Shah, D. Judge, P. Elliott, 2018, The New England journal of medicine.

Management of Heart Failure in Cardiac Amyloidosis Using an Ambulatory Diuresis Clinic.

S. Russell, D. Judge, J. Vaishnav, 2020, American heart journal.

Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity

D. Judge, C. D’Adamo, E. Brown, 2022, Journal of Cardiovascular Translational Research.

Counseling Family Members and Monitoring for Evidence of Disease in Asymptomatic Carriers of Amyloid Transthyretin Cardiac Amyloidosis.

D. Judge, Naomi Barker, 2022, American Journal of Cardiology.

Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C-Related Dilated Cardiomyopathy.

L. Mestroni, D. Judge, C. Macrae, 2022, The American journal of cardiology.

Giant Ring Mitochondria in a Patient With Heart Failure and Cerebral White Matter Disease Resulting From an MT-TL1 Mitochondrial Gene Mutation.

M. Halushka, D. Judge, L. Barouch, 2017, Journal of cardiac failure.

Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure

D. Judge, Wayne N. Campbell, H. Chahal, 2014, Journal of Community Hospital Internal Medicine Perspectives.

GLA-Ring Opportunities and Challenges for Fabry Disease.

D. Judge, A. Hagège, I. Okwuosa, 2016, Journal of the American College of Cardiology.

Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis

D. Judge, Rosanne Rouf, K. Zehr, 2018, Case reports in cardiology.

Arrhythmogenic Right Ventricular Dysplasia: A United States Experience

S. Russell, H. Calkins, D. Bluemke, 2005, Circulation.

Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis

D. Judge, C. Basso, C. Bezzina, 2017, Cardiovascular research.

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

H. Calkins, P. Ellinor, S. Priori, 2011, Heart rhythm.

Genetic testing for dilated cardiomyopathy in clinical practice.

Nicole M. Johnson, W. Chung, J. Seidman, 2012, Journal of cardiac failure.

E713K in desmoglein-2 and arrhythmogenic right ventricular dysplasia/cardiomyopathy

D. Judge, 2008, Nature Clinical Practice Cardiovascular Medicine.

Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.

S. Russell, H. Calkins, T. Abraham, 2011, Journal of the American College of Cardiology.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.

M. Link, L. Mestroni, H. Calkins, 2019, Heart rhythm.

TARGETED MYBPC3 KNOCK-OUT MICE WITH NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY EXHIBIT STRUCTURAL MITRAL VALVE ABNORMALITIES

R. Levine, D. Judge, A. Hagège, 2011 .

Familial Hypertrophic Cardiomyopathy Associated with Cardiac β-Myosin Heavy Chain and Troponin I Mutations

Nicole M. Johnson, D. Judge, K. Holmes, 2008, Pediatric Cardiology.

Retracted and Republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2019, European heart journal.

Lessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants

J. Clark, A. Jackson, L. Lenert, 2022, Journal of personalized medicine.

Correction: Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

D. Judge, K. McBride, M. Vatta, 2019, Genetics in Medicine.

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

Wolfram Kress, Julie De Backer, Jan Hellemans, 2005, Nature Genetics.

Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

H. Calkins, D. Judge, Huei-Sheng Vincent Chen, 2012, Nature.

The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients.

S. Russell, M. Halushka, D. Judge, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

D. Judge, H. Dietz, C. Ward, 2007, Nature Medicine.

TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome

D. Judge, H. Dietz, F. Martínez-Murillo, 2004 .

LMNA‐associated cardiocutaneous progeria: An inherited autosomal dominant premature aging syndrome with late onset

D. Judge, H. Dietz, M. Lindsay, 2013, American journal of medical genetics. Part A.

Defective Solar Protection in Xeroderma Pigmentosum and Cockayne Syndrome Patients

D. Judge, Colette M. Aprhys, 2006 .

Marfan's syndrome

D. Judge, H. Dietz, 2005, The Lancet.

Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association.

Paul J. Wang, D. Judge, A. Domenighetti, 2017, Circulation.

Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy

Matthew Miyamoto, Chulan Kwon, H. Calkins, 2021, Science Translational Medicine.

Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.

John F. Robinson, L. Mestroni, J. Healey, 2019, The Journal of clinical investigation.

A Clinical Approach to a Family History of Sudden Death

D. Judge, B. Tan, 2012, Circulation. Cardiovascular genetics.

An Evidence-based Assessment of Genes in Dilated Cardiomyopathy

D. Judge, J. Ware, R. L. Lekanne Deprez, 2020, medRxiv.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.

M. Link, L. Mestroni, H. Calkins, 2019, Heart rhythm.

Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

D. Judge, K. McBride, M. Vatta, 2018, Genetics in Medicine.

Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline.

D. Judge, K. McBride, M. Vatta, 2018, Journal of cardiac failure.

Role of Genetic Testing in Inherited Cardiovascular Disease: A Review

C. Caleshu, D. Judge, I. Olivotto, 2017, JAMA cardiology.

Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy

R. Hauer, S. Russell, H. Calkins, 2015, Heart.

Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated Cardiomyopathy.

S. Gottlieb, D. Judge, E. Kransdorf, 2022, JAMA cardiology.

Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo: Segregation and Haplotype Analysis of a Multinational Cohort.

H. Calkins, R. Zwart, E. Schulze-Bahr, 2019, Circulation. Genomic and precision medicine.

Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members

Stefan L. Zimmerman, Hugh Calkins, Crystal Tichnell, 2015, Circulation. Cardiovascular genetics.

Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise.

R. Hauer, H. Calkins, T. Callis, 2011, Journal of the American College of Cardiology.

Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.

Sarah J. Parker, D. Judge, H. Dietz, 2014, The Journal of clinical investigation.

Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis

R. Labaudinière, D. Judge, M. Maurer, 2016, Neurology and Therapy.

Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story

D. Judge, J. Kelly, J. Patel, 2021, Drug design, development and therapy.

TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.

D. Judge, H. Dietz, F. Martínez-Murillo, 2004, The Journal of clinical investigation.

Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy

H. Calkins, A. Kleber, D. Judge, 2014, Science Translational Medicine.

Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate With a Brugada Syndrome Phenotype

S. Priori, V. Novelli, C. Napolitano, 2014, Circulation.

University of Groningen A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy Cadrin-Tourigny,

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2019 .

Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency

D. Judge, T. Park, D. Tian, 2019, PLoS genetics.

Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.

Dong I. Lee, Hideki Uosaki, D. Kass, 2017, Cell reports.

Use of Genetics in the Clinical Evaluation and Management of Heart Failure

D. Judge, Rosanne Rouf, 2010, Current treatment options in cardiovascular medicine.

The complex genetics of atrial fibrillation.

D. Judge, 2012, Journal of the American College of Cardiology.

The molecular genetics of Marfan syndrome and related disorders

P. Robinson, D. Milewicz, D. Judge, 2006, Journal of Medical Genetics.

Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Jessica Geubtner, D. Judge, H. Dietz, 2004, The Journal of clinical investigation.

Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

L. Steinmetz, R. Nussbaum, L. Mestroni, 2019, Circulation. Heart failure.

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Benjamin S. Brooke, Nishant Patel, Bart Loeys, 2008, The New England journal of medicine.

Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism

D. Judge, H. Dietz, J. Habashi, 2011, Science.

Epidemiology of the inherited cardiomyopathies

D. Judge, W. McKenna, 2020, Nature Reviews Cardiology.

Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

Sanjiv J. Shah, S. Gottlieb, D. Judge, 2016, Journal of the American College of Cardiology.

Extensive cardiac allograft vasculitis and concurrent fat necrosis 6 years after orthotopic heart transplantation.

M. Halushka, D. Judge, W. Baldwin, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Characterization of microsatellite markers flanking FBN1: utility in the diagnostic evaluation for Marfan syndrome.

D. Judge, H. Dietz, N. Biery, 2001, American journal of medical genetics.

Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.

R. Falk, A. Quyyumi, D. Judge, 2015, Circulation. Heart failure.

Reversible cardiomyopathy caused by administration of interferon alpha.

M. Halushka, D. Judge, E. Kasper, 2005, Nature clinical practice. Cardiovascular medicine.

Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy

D. Kass, D. Judge, K. Wagner, 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy

D. Kass, S. Russell, D. Herzka, 2014, Annals of neurology.

Cardiac Management of the Patient With Duchenne Muscular Dystrophy

D. Judge, S. Raman, P. Eghtesady, 2018, Pediatrics.

Translational Research on the Mitral Valve: from Developmental Mechanisms to New Therapies

R. Levine, R. Markwald, D. Judge, 2011, Journal of cardiovascular translational research.

Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction

S. Russell, D. Judge, N. Gilotra, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

The variable natural history of idiopathic dilated cardiomyopathy.

S. Russell, D. Judge, K. Parakh, 2012, The Israel Medical Association journal : IMAJ.

Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy

J. Seidman, D. Judge, S. Goland, 2021, Circulation.

Use of genetics in the clinical evaluation of cardiomyopathy.

D. Judge, 2009, JAMA.

A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome

Jennifer E Van Eyk, M. Caulfield, B. Rusholme, 2015, eLife.

The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.

H. Calkins, R. Berger, D. Judge, 2006, Heart rhythm.

Translating Cardiovascular Knowledge: A Global Health Perspective

D. Judge, C. Rabadán-Diehl, 2015, Journal of Cardiovascular Translational Research.

Multi-Scale Biomechanical Remodeling in Aging and Genetic Mutant Murine Mitral Valve Leaflets: Insights into Marfan Syndrome

Russell A. Gould, D. Judge, H. Dietz, 2012, PloS one.

ATTR Epidemiology, Genetics, and Prognostic Factors

D. Judge, W. Mostertz, Chukwuemeka A. Obi, 2022, Methodist DeBakey cardiovascular journal.

Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis.

Sanjiv J. Shah, D. Kass, S. Russell, 2020, JACC. Heart failure.

Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

H. Calkins, D. Judge, C. Camm, 2013, Heart rhythm.

Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices.

S. Russell, D. Judge, K. Faridi, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Short-Term Effects of Right-Left Heart Sequential Cardiac Resynchronization in Patients With Heart Failure, Chronic Atrial Fibrillation, and Atrioventricular Nodal Block

Andrew P. Kramer, D. Kass, B. Fetics, 2004, Circulation.

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.

Sanjiv J. Shah, R. Falk, D. Judge, 2019, Journal of the American College of Cardiology.

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

D. Judge, M. Maurer, B. Drachman, 2015, Heart Failure Reviews.

Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis

T. Tripp, D. Judge, G. Merlini, 2013, Journal of Cardiovascular Translational Research.

Transthyretin Cardiac Amyloidosis: Pathogenesis, Treatments, and Emerging Role in Heart Failure with Preserved Ejection Fraction

D. Judge, M. Mukherjee, V. Ton, 2014, Clinical Medicine Insights. Cardiology.

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study

D. Judge, P. García-Pavía, G. Merlini, 2020, European journal of heart failure.

The prevalent I686T human variant and loss of function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.

D. Judge, M. Zile, H. Sucov, 2020, Human Molecular Genetics.

Comprehensive Versus Targeted Genetic Testing in Children with Hypertrophic Cardiomyopathy

Nicole M. Johnson, D. Judge, A. Murphy, 2016, Pediatric Cardiology.

Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants

L. Mestroni, E. Ashley, H. Calkins, 2021, Circulation.

Association of Common Variations on Chromosome 4q25 and Left Atrial Volume in Patients with Atrial Fibrillation

Stefan L. Zimmerman, H. Calkins, D. Judge, 2015, Clinical Medicine Insights: Cardiology.

Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial

G. Ewald, M. Wheeler, S. Gottlieb, 2023, Circulation.

Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

R. Hauer, H. Calkins, D. Judge, 2016, European heart journal.

Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

S. Russell, H. Calkins, D. Judge, 2017, Circulation. Heart failure.

Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions

Angharad M Roberts, V. Novelli, W. Zareba, 2023, Genome Medicine.

FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy

L. Mestroni, H. Calkins, D. Judge, 2020, Journal of Medical Genetics.

Absence of a Primary Role for SCN10A Mutations in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

H. Calkins, D. Judge, M. Polydefkis, 2016, Journal of Cardiovascular Translational Research.

Mutation‐Positive Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: The Triangle of Dysplasia Displaced

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2013, Journal of cardiovascular electrophysiology.

One step closer to personalized genomic medicine.

D. Judge, 2010, European Heart Journal.

Efficacy and Safety of ARRY-371797 in LMNA-Related Dilated Cardiomyopathy: A Phase 2 Study

L. Mestroni, E. Ashley, M. Wheeler, 2022, Circulation. Genomic and precision medicine.

Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

S. Russell, H. Calkins, D. Bluemke, 2007, The American journal of cardiology.

Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives.

G. Ewald, M. Wheeler, S. Gottlieb, 2023, Journal of the American College of Cardiology.

Conductance catheter-based assessment of arterial input impedance, arterial function, and ventricular-vascular interaction in mice.

Pascal Verdonck, Patrick Segers, Nikos Stergiopulos, 2005, American journal of physiology. Heart and circulatory physiology.

Cardiac Amyloidosis

Liza S. M. Wong, D. Judge, L. S. Wong, 2020, Clinical Cardiogenetics.

R. Hauer, H. Calkins, E. Behr, 2021, Circulation. Genomic and precision medicine.

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)

R. Hauer, H. Calkins, A. Wilde, 2018, Journal of cardiovascular electrophysiology.

Abstract 10980: Myositis, Myocarditis, and Mitochondria: A Thread Connecting the Myofilaments

M. Halushka, D. Judge, A. Gelber, 2015 .

Prolonged RV endocardial activation duration: a novel marker of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

D. Kass, S. Russell, H. Calkins, 2009, Heart rhythm.

The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia

D. Judge, M. Streiff, Elise Gelwan, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Intracardiac giant cells after left ventricular assist device placement.

D. Yuh, M. Halushka, D. Judge, 2007, The Journal of Heart and Lung Transplantation.

Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin Amyloidosis

D. Judge, G. Ebenezer, M. Polydefkis, 2023, Neurology.

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a family affair.

D. Judge, 2011, Circulation.

A family with a complex clinical presentation characterized by arrhythmogenic right ventricular dysplasia/cardiomyopathy and features of branchio‐oculo‐facial syndrome

E. Zackai, H. Calkins, D. Judge, 2013, American journal of medical genetics. Part A.

Impact of Donor Hemodynamics on Recipient Survival in Heart Transplantation.

Andrew J. Sauer, D. Judge, M. Kittleson, 2023, Journal of cardiac failure.

Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.

G. Ewald, M. Wheeler, H. Rehm, 2023, JAMA.

A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients

L. Mestroni, M. P. van den Berg, D. Judge, 2023, Journal of cardiovascular translational research.

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2022, European heart journal.

Arrhythmogenic Cardiomyopathy.

D. Corrado, D. Judge, C. Basso, 2021, Circulation research.

Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.

D. Judge, M. Mukherjee, V. Ton, 2014, Clinical Medicine Insights. Cardiology.

Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

D. Judge, K. McBride, M. Vatta, 2018, Genetics in Medicine.

Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy

D. Judge, S. Chelko, Nuria Amat-Alarcon, 2022, International journal of molecular sciences.

Arrhythmogenic cardiomyopathy : pathology , genetics , and concepts in pathogenesis CHAPTER 2

D. Judge, C. Basso, C. Bezzina, 2019 .

Corrigendum: Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

D. Judge, H. Dietz, J. Habashi, 2007, Nature Network Boston.

Abstract 19616: AG10 Stabilizes Pathogenic TTR Variants With High Potency - Potential for an Effective Treatment for TTR Cardiomyopathy

I. Graef, D. Judge, M. Liedtke, 2017 .

Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

H. Calkins, D. Judge, P. Scheel, 2020, Journal of the American Heart Association.

Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis

Nicole M. Johnson, M. Halushka, D. Judge, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Retracted and Republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

Stefan L. Zimmerman, R. Hauer, H. Calkins, 2019, European heart journal.

Reader‐ and Instrument‐Dependent Variability in the Electrocardiographic Assessment of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

H. Calkins, T. Abraham, D. Judge, 2011, Journal of cardiovascular electrophysiology.

Anticipating adaptation: tracking the impact of planned and unplanned adaptations during the implementation of a complex population-based genomic screening program.

D. Judge, P. Ramos, K. Hunt, 2023, Translational behavioral medicine.

Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy.

A. Kleber, D. Judge, J. Saffitz, 2016, JCI insight.

Yield of serial evaluation in at-risk family members of patients with ARVD/C.

Stefan L. Zimmerman, H. Calkins, D. Bluemke, 2014, Journal of the American College of Cardiology.

Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.

Sarah J. Parker, D. Judge, H. Dietz, 2014, The Journal of clinical investigation.

Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy

H. Calkins, A. Kleber, D. Judge, 2014, Science Translational Medicine.

Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia

H. Calkins, T. Abraham, D. Judge, 2009, Circulation.

The molecular genetics of Marfan syndrome and related disorders

D. Milewicz, D. Judge, H. Dietz, 2006, Journal of Medical Genetics.

Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated

D. Atsma, D. Judge, H. Tandri, 2015 .

Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity.

R. Hauer, H. Calkins, D. Judge, 2013, Heart rhythm.

Further evidence of harm from exercise in ARVD/C.

D. Judge, S. Chelko, 2015, Journal of the American College of Cardiology.

Fluctuating creatinine in the cardiac unit.

L. Sokoll, D. Judge, M. Marzinke, 2015, Clinica chimica acta; international journal of clinical chemistry.